An internationally recognized expert in kinase signaling and co-inventor of the technology, Dr. Leopold pioneered the MEK inhibitor field. She is Program Co-Leader of Developmental Therapeutics at Rogel Cancer Center and was previously Executive Director of Mechanistic& larget Biology at Phizer Global R&D.
This person is not in any offices